North America Legal Chronicle. July 13, 2023

Tonix Pharmaceuticals’ $25 Million Acquisition of FDA-Approved Products from Upsher-Smith Laboratories

By Laura Testa

Lowenstein represented Tonix Pharmaceuticals Holding Corp. in the transaction. Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP), a clinical-stage biopharmaceutical company, announced its $25 million acquisition of two...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
North America Legal Chronicle. February 15, 2023

Tonix Pharmaceuticals’ Acquisition of Preclinical Infectious Disease Portfolio from Healion Bio

By Laura Testa

Lowenstein represented Tonix Pharmaceuticals Holding Corp. in the transaction. Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) signed an agreement to acquire assets of Healion Bio, Inc., including its...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here